Earnings call transcripts

Earnings call transcripts with speakers and Q&A, usually within hours. Each one comes with a summary, the guidance management gave, and what analysts pressed on, free to read.

3,453 transcripts · 1,641 companiesHow to read a callBy API: the earnings call transcripts API.

Older calls

Page 54 of 288 · 3,453 calls

  • Stantec (STN) Q2 2026 earnings call

    Management framed Q2 as evidence of resilient demand and execution, with second-half growth acceleration expected despite temporary U.S. project delays.

    Aug 13, 2026Confident0.76
  • WhiteHawk Minerals (WHK) Q2 2026 earnings call

    Management framed White Hawk as a downside-protected, dividend-paying mineral owner with acquisition growth and natural-gas demand upside ahead.

    Aug 13, 2026Confident0.72
  • Aebi Schmidt Holding (AEBI) Q2 2026 earnings call

    Management framed Q2 as evidence that backlog conversion, integration synergies and operating efficiencies are lifting profitability faster than sales, despite temporary cost pressures.

    Aug 13, 2026Positive0.65
  • Arrive AI (ARAI) Q2 2026 earnings call

    Management framed the call as a commercialization inflection, emphasizing product availability, enterprise pipeline progression, and financing optionality over current scale.

    Aug 13, 2026Positive0.45
  • CorMedix (CRMD) Q2 2026 earnings call

    Management framed the quarter around navigating the reimbursement transition, expanding DefendCAT access, and advancing Reseo while preserving flexibility on investment and guidance.

    Aug 13, 2026Positive0.68
  • EquipmentShare.com (EQPT) Q2 2026 earnings call

    Management framed demand, pricing and mega-project visibility as stronger than guidance, with Q2 fleet absorption pulling activity forward and leaving upside potential.

    Aug 13, 2026Confident0.90
  • Figure Technology Solutions (FIGR) Q2 2026 earnings call

    Management framed accelerating partner migration to Figure Connect as the growth engine, accepting lower take rates in exchange for capital-light, higher-margin expansion.

    Aug 13, 2026Confident0.78
  • LENSAR (LNSR) Q2 2026 earnings call

    Management framed Q2 as evidence of a post-merger reset, with utilization and recurring revenue building momentum ahead of renewed commercial investment. 24.1% U.S.

    Aug 13, 2026Confident0.76
  • Lucid Diagnostics (LUCD) Q2 2026 earnings call

    Management framed the quarter as commercial infrastructure-building while Medicare coverage remains pending, highlighting early payer validation and a shift toward more collectible testing volume.

    Aug 13, 2026Positive0.55
  • Intuitive Machines (LUNR) Q2 2026 earnings call

    Management framed the quarter as evidence that acquisitions and production investment are building an integrated space infrastructure prime, with execution and cash use still important constraints.

    Aug 13, 2026Confident0.78
  • MediWound (MDWD) Q2 2026 earnings call

    Management framed the quarter around S-Corex trial execution and a second-half revenue ramp from Vericel and government-backed programs.

    Aug 13, 2026Mildly positive0.35
  • SOLV Energy (MWH) Q2 2026 earnings call

    Management framed the quarter as evidence of a favorable demand cycle and a broader lifecycle-services platform, with execution and backlog supporting higher full-year expectations.

    Aug 13, 2026Confident0.78

Companies covered

1,641 companies

157 more under A